Clinical Trials Logo

BCR-ABL Positive clinical trials

View clinical trials related to BCR-ABL Positive.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT01699217 Active, not recruiting - Clinical trials for Chronic Myeloid Leukaemia

Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase

CML0912
Start date: June 21, 2013
Phase:
Study type: Observational

The GIMEMA CML Working Party promotes a multicentre, observational, prospective study of CML patients treated frontline with NIL. Patients will be followed for 5 years. This study will help the definition of guidelines for the treatment of CML patients in early CP.